As Ebola rages, Moderna and others are racing to develop an mRNA vaccine for the rare Bundibugyo virus driving the current ...
A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in ...
India, June 23 -- The US Food and Drug Administration's (FDA) independent vaccine advisory committee has recommended approval ...
5don MSN
FDA approves world's first mRNA-based flu vaccine, signaling start of a new illness-prevention era
The vaccine, intended for people 50 and older, is based on mRNA technology and was found in an advanced trial to be more ...
A panel of advisers to FDA gave its endorsement to a seasonal mRNA flu vaccine that was developed by Moderna and that earlier ...
San Diego —The vaccine developer Vaxart is aiming to get back on track after a turbulent year.
Health and Human Services Secretary Robert F. Kennedy Jr.’s decision to terminate nearly $500 million in government funding for mRNA vaccine development has alarmed public health experts. “This is a ...
Preclinical study demonstrates effectiveness of experimental mRNA vaccine against neuroblastoma, reducing tumour size by 70 ...
A new study from RCSI University of Medicine and Health Sciences demonstrates a novel approach in anticancer vaccine ...
HHS Secretary Robert F. Kennedy Jr.'s decision to cancel $500 million in funding and wind down development of mRNA vaccines is a disastrous one -- especially with the looming threat of an H5N1 avian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results